Clinical Trial Update: Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating ZARNESTRA in combination with Tamoxifen for advanced or metastatic breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tamoxifen (tamoxifen)
• ZARNESTRA

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Breast Neoplasms | Phase 2 | Status: TERMINATED